Abbott Laboratories closed 6.08% below its 52-week high of $141.23, which the company reached on March 4th.

Gov. Greg Abbott (R-TX) has yet to call a special election to fill recently deceased Rep. Sylvester Turner's seat in Texas's ...

Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 ...

Valued at a market cap of $228.3 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, ...

Abbott Laboratories recently announced successful outcomes from its TRILUMINATE™ Pivotal trial for the TriClip™ system, showcasing significant improvements in patient outcomes for tricuspid ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

Barclays analyst Matt Miksic maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of $158.00.

On Feb. 19, students from Roberts Middle School in Cuyahoga Falls, Ohio, toured R.D. Abbott's Barberton Service Center, which ...

The ablation catheter manufacturing clean room at Abbott Labs in Plymouth in 2021. Abbott recently secured approval to market its new pulse field ablation device for atrial fibrillation in Europe ...

Abbott Laboratories has maintained a strong position in the healthcare industry, with a diverse portfolio spanning medical devices, diagnostics, nutrition, and branded generic pharmaceuticals.

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...